NCT01481480

Brief Summary

A massive tear of the rotator cuff is a debilitating condition that causes pain, significant impairments in strength, and resultant loss of activity of the affected arm. To our knowledge, there is no Level 1 evidence comparing surgical procedures to treat massive rotator cuff tears. Adding the first randomized controlled trial to will be a substantial contribution to the current body of evidence available in the subject of massive rotator cuff tears. Most studies found in the literature following patients with massive rotator cuff tears are retrospective, have small numbers of patients, offer no control group and do not adequately compare treatment methods.Moreover, there is no consensus from experts regarding which treatment is superior. Our multicentre orthopaedic study group proposes a multicentre randomized clinical trial prospectively comparing latissimus dorsi tendon transfer to arthroscopic management for the treatment of massive rotator cuff tears. This study will include the use of comprehensive functional, motor and radiographic outcome assessments.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 29, 2011

Completed
8 months until next milestone

Study Start

First participant enrolled

August 1, 2012

Completed
9.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

October 20, 2020

Status Verified

October 1, 2020

Enrollment Period

9.1 years

First QC Date

November 24, 2011

Last Update Submit

October 19, 2020

Conditions

Keywords

shoulderrotator cufftendon transferarthroscopic repair

Outcome Measures

Primary Outcomes (1)

  • Constant-Murley score

    Constant-Murley score at 2 years

    2 years

Secondary Outcomes (1)

  • Quick Dash

    2 years

Study Arms (2)

Latissimus dorsi tendon transfer

EXPERIMENTAL

A Latissimus dorsi tendon transfer is performed

Procedure: Latissimus dorsi tendon transfer

Arthroscopic repair

ACTIVE COMPARATOR

An arthroscopic repair is performed

Procedure: Arthroscopic repair

Interventions

Latissimus dorsi tendon transfer

Latissimus dorsi tendon transfer

Arthroscopic repair

Arthroscopic repair

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men or women aged 40 to 65 years of age
  • Massive rotator cuff tear, identified by MRI as being greater than 4cm in greatest diameter.
  • Provision of informed consent

You may not qualify if:

  • Absence of functioning latissimus dorsi muscle (assessed by "cough test"
  • Absence of subscapularis muscle insertion (assessed by MRI)
  • Glenohumeral arthritis of Grade 2 or higher, including evidence of acromio-humeral arthritis
  • Acute tears (identifiable injury which precluded symptoms in past 6 months)
  • Neurologic injury causing paralysis of affected shoulder girdle/arm
  • Limited life expectancy due to significant medical co-morbidity or medical contraindication to surgery (ASA Grade IV or higher)
  • Anticipated problems, in the judgement of the investigators, with maintaining follow-up (i.e. patients with no fixed address, patients not mentally competent to give consent, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto Western Hospital, St. Michael's Hospital, Holland Centre

Toronto, Ontario, Canada

Location

Study Officials

  • Michael McKee, MD, FRSC(C)

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2011

First Posted

November 29, 2011

Study Start

August 1, 2012

Primary Completion

September 1, 2021

Study Completion

December 1, 2021

Last Updated

October 20, 2020

Record last verified: 2020-10

Locations